Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06021171
Other study ID # 2021-44-0701
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 15, 2021
Est. completion date May 15, 2022

Study information

Verified date August 2023
Source King's College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Iron deficiency (ID) is the most common micronutrient deficiency worldwide, and poor iron bioavailability is a major cause. While 30% of female athletes are affected by ID, and its consequences are highly relevant to athletic performance, ID affects women and children around the world with consequences just as relevant, if not more so (e.g. school performance, work capacity and thus wage earning). With poor iron absorption being a cause of ID in active women, it is especially important to discover simple ways to improve iron (Fe) uptake. While some studies have suggested that consumption of prebiotic fiber may improve Fe absorption in animal models, there have been few studies examining the effects of synbiotic supplementation (consumption of both a prebiotic and probiotic that work together) on Fe uptake in adult females (athletes and non-athletes). A recent pilot study demonstrated a substantial improvement in Fe uptake in female athletes after 4 and 8 weeks of synbiotic supplementation compared to placebo during Fe repletion with a low dose of ferrous sulfate (FeSO4). If synbiotic supplementation can improve the Fe bioavailability of FeSO4 (which is ~30%) in ID women during repletion of Fe status, it could possibly improve the Fe bioavailability of non-heme Fe sources, as well as mixed meals. Research Question: What is the effect of synbiotic supplementation (a supplement containing a prebiotic + a probiotic), compared to prebiotic supplementation or a placebo, on Fe uptake and the gut microbiome in ID athletes during low-dose Fe repletion? Hypothesis: In the proposed study, we hypothesize that synbiotic supplementation along with Fe repletion with a low dose of FeSO4 will have greatest impact on athletes' Fe uptake due to alterations in the microbiome, which will be assessed.


Description:

The following Specific Aims will help us to answer this research question: To screen the iron status of athletes at the beginning of training season and determine the prevalence of anemia and iron depletion on our NCAA Division III campus. To determine the differences in Fe uptake with consumption of a synbiotic, prebiotic, and placebo supplements along with low-dose Fe supplementation in ID athletes. To determine the differences in the microbiome with consumption of a synbiotic, prebiotic, and placebo supplements along with low-dose Fe supplementation in ID female athletes. This aim will help us mechanism behind change in iron status with a functional fiber (e.g. synbiotic supplementation). This data is essential to advance our understanding of how Fe uptake in active persons can be enhanced by functional fiber supplementation, as well as by REAL foods containing functional fibers, which could help ameliorate ID not only for athletes here in the US but for people around the globe. The design is a randomized, placebo-controlled crossover trial, which will use each participant as her/his own control, in addition to a placebo treatment being administered in a counter-balanced order with the other treatments. Participants: King's is a Division III College and currently has >85 eligible female athletes on the rosters of a variety of competitive sports teams. During a recent RCT, about 30 active women were screened and >30% were ID (1). For the proposed study, given the effect size observed in previous work (6), we need n=10 to complete the 18-week randomized crossover trial (e.g. so recruiting n=13 would allow for a "normal" 20% attrition rate during the trial due to injuries, illnesses, etc). Iron Status Screening: Athletes from King's will be asked to volunteer via recruitment email. To address Aim 1, at baseline (and after NCAA health clearance), athletes will have their iron status screened via venous blood sample at the beginning of their season in the Human Performance Lab in the Alley Center (Complete Blood Count, which includes Hgb); Serum ferritin; C-Reactive Protein for inflammation adjustment of ferritin). Anthropometrics and body composition will be measured and health, dietary and training information will also be collected. Standard demographic information, and medical history will be self-reported by each participant using computer-based questionnaires. All athletes with normal iron status (Hgb >12.0 g/dL AND sFer>30.0 µg/L) will be given their iron status results and offered a Nutrition Consultation by a MS Nutrition Student under the supervision of the PI. Athletes will not be eligible to participate in the study if pregnant, wishing to become pregnant, breastfeeding, having a condition or taking medication impacting Fe status, or not healthy enough to train/participate in their sport. Crossover Trial: To address Aims 2 and 3, women athletes identified as ID (sFer<30.0 µg/L) will be invited to participate in a 18-week double-blind, randomized, crossover trial with concurrent daily Fe supplementation (100 mg FeSO4/d, Puritan's Pride). Participating ID athletes will receive the following treatments for 4 weeks each, in a randomized, counter-balanced order: a) synbiotic supplement (RegularGirl), b) prebiotic supplement (SunFiber), and c) placebo (maltodextrin). There will be a 3-week wash-out period between treatments (see Figure 1). In our pilot study, we observed a strong response within a 4-week time period. Volunteers will be asked to mix the supplemental functional fiber source (or placebo) packet, all identically packaged and only visible as white powder, with any food or beverage once daily. They will also asked to consume 100 mg FeSO4 per day as a single low-dose Fe tablet once per day, either in the morning or in the evening, avoiding consumption with coffee/tea or supplemental calcium source. Throughout the 18-week study, athletes will be asked to complete a daily training, medication, compliance, stool (using the Bristol Stool Scale, BSS) and GI symptom log. Compliance will also be measured by research staff via weekly pill and packet counts. Iron status (as described in Screening above) and dietary intake (via 24-h recall and FFQ) will be measured at the beginning and end of each treatment point of the trial (see "X" in Figure 1). Fecal samples will be collected at beginning and end of each timepoint for analysis of the microbiome (see "X" in Figure 1) using self-collection vials provided (OMNIgene-GUT, OMG-200, DNA GenoTek). Volunteers will not be asked to alter their usual food/ dietary intake in any way during the trial. At the end of the study, athletes will be given their endpoint lab results and offered a Nutrition Consultation by a MS Nutrition Student under the supervision of the PI. Iron status (as described in Screening above) and dietary intake (via 24-h recall and FFQ) will be measured at the beginning and end of each treatment point of the trial (see "X" in Figure 1). Fecal samples will be collected at beginning and end of each timepoint for analysis of the microbiome (see "X" in Figure 1) using self-collection vials provided (OMNIgene-GUT, OMG-200, DNA GenoTek). Volunteers will not be asked to alter their usual food/ dietary intake in any way during the trial. At the end of the study, athletes will be given their endpoint lab results and offered a Nutrition Consultation by a MS Nutrition Student under the supervision of the PI. Time and effort: 15.5 hours over the 18 week study Blood sampling and body measurements will take about 15 min, 6x during the trial (1.5 h total) Completion of forms will take about 15 min 6 x during the trial (1.5 h total) Stool collection will take about 5 min, 6 times during trial (0.5 h total) Meeting at the Alley Center Human Performance Lab weekly will take ~ 5 min, 18x over the course of the study (1.5 h total) Consumption of iron supplement and packet every day and daily record-keeping will take <5 min/day * 126 days during 18 week study (<10.5 h total) Data analysis plan: All analyses of sFer will be adjusted for inflammation. Briefly, GLM Repeated measures ANOVA will be used to assess the effect of the treatments on iron status, GI symptoms, etc. (Time-by-Tx effects will be examined). All statistical analyses will be performed using SPSS (most recent version), and results will be considered statistically significant at p<0.05 for main effects.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date May 15, 2022
Est. primary completion date May 15, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - 18 years of age or older - currently participating in or training for their sport Exclusion Criteria: - Pregnant, or wishing to become pregnant - Breastfeeding - Having a condition or taking medication impacting iron status - Not healthy enough to train for/participate in their sport.

Study Design


Intervention

Dietary Supplement:
Partially hydrolyzed guar gum + bifidobacterium lactis
Synbiotic Supplement: Contains 5 grams of prebiotic fiber (Sunfiber®) and 8 billion active probiotics (Bifidobacterium lactis).
Partially hydrolyzed guar gum
5 g Partially hydrolyzed guar gum
Maltodextrin
5 g Maltodextrin

Locations

Country Name City State
United States King's College Wilkes-Barre Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
King's College

Country where clinical trial is conducted

United States, 

References & Publications (7)

DellaValle DM, Glahn RP, Shaff JE, O'Brien KO. Iron Absorption from an Intrinsically Labeled Lentil Meal Is Low but Upregulated in Women with Poor Iron Status. J Nutr. 2015 Oct;145(10):2253-7. doi: 10.3945/jn.115.217273. Epub 2015 Sep 2. — View Citation

DellaValle DM, Haas JD. Impact of iron depletion without anemia on performance in trained endurance athletes at the beginning of a training season: a study of female collegiate rowers. Int J Sport Nutr Exerc Metab. 2011 Dec;21(6):501-6. doi: 10.1123/ijsnem.21.6.501. — View Citation

Dellavalle DM, Haas JD. Iron status is associated with endurance performance and training in female rowers. Med Sci Sports Exerc. 2012 Aug;44(8):1552-9. doi: 10.1249/MSS.0b013e3182517ceb. — View Citation

Freitas Kde C, Amancio OM, de Morais MB. High-performance inulin and oligofructose prebiotics increase the intestinal absorption of iron in rats with iron deficiency anaemia during the growth phase. Br J Nutr. 2012 Sep 28;108(6):1008-16. doi: 10.1017/S0007114511006301. Epub 2011 Dec 15. — View Citation

Laparra JM, Diez-Municio M, Herrero M, Moreno FJ. Structural differences of prebiotic oligosaccharides influence their capability to enhance iron absorption in deficient rats. Food Funct. 2014 Oct;5(10):2430-7. doi: 10.1039/c4fo00504j. Epub 2014 Aug 11. — View Citation

Sandroni A, House E, Howard L, DellaValle DM. Synbiotic Supplementation Improves Response to Iron Supplementation in Female Athletes during Training. J Diet Suppl. 2022;19(3):366-380. doi: 10.1080/19390211.2021.1887423. Epub 2021 Feb 22. — View Citation

Scholz-Ahrens KE, Schrezenmeir J. Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr. 2007 Nov;137(11 Suppl):2513S-2523S. doi: 10.1093/jn/137.11.2513S. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Blood serum level of ferritin biomarker of iron status, iron stores, use to calculate Total body iron baseline (0), 4, 8, 12, 16, 18 weeks
Primary Blood level of hemoglobin biomarker of iron status baseline (0), 4, 8, 12, 16, 18 weeks
Primary Blood serum level of soluble transferrin receptor biomarker of iron status, tissue iron status, use to calculate Total body iron baseline (0), 4, 8, 12, 16, 18 weeks
Primary Gut microbiome data Fecal samples to yield gut bacterial taxa baseline (0), 4, 8, 12, 16, 18 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06027801 - Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity N/A
Completed NCT02282553 - Gastric Capsule Examination for Iron Deficiency Anaemia N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Phase 4
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01307007 - Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Phase 2
Completed NCT00982007 - Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Phase 3
Completed NCT00198848 - Iron Supplementation Among Adolescent Girls in India N/A
Completed NCT01166451 - The Anemia Control Program: High or Low Iron Supplementation N/A
Recruiting NCT03893045 - A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Phase 3
Recruiting NCT03817957 - Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency Phase 3
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Completed NCT03618914 - Anemia and Inflammation
Completed NCT03940430 - Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Phase 2/Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Completed NCT03237065 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department